Trials / Completed
CompletedNCT06854952
A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity
A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 167 (actual)
- Sponsor
- Terns, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase 2a multicenter, randomized, double-blind, placebo-controlled clinical trial studying the efficacy, safety, and tolerability of orally administered TERN-601 in adults with overweight or obesity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TERN-601 | Investigational drug |
| OTHER | Matching Placebo | Matching placebo |
Timeline
- Start date
- 2025-03-07
- Primary completion
- 2025-08-19
- Completion
- 2025-09-19
- First posted
- 2025-03-03
- Last updated
- 2025-11-06
Locations
17 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06854952. Inclusion in this directory is not an endorsement.